Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in Net LoansChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abvc Biopharma (ABVC) Non-cash Items (2022 - 2024)

Abvc Biopharma (ABVC) has disclosed Non-cash Items for 4 consecutive years, with $258710.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items changed N/A year-over-year to $258710.0, compared with a TTM value of $258710.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $258710.0, changed N/A over the prior year.
  • Non-cash Items was $258710.0 for Q4 2025 at Abvc Biopharma, roughly flat from $258710.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.6 million in Q4 2022 and bottomed at $258710.0 in Q2 2024.
  • Average Non-cash Items over 4 years is $1.3 million, with a median of $258710.0 recorded in 2024.
  • Peak annual rise in Non-cash Items hit 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
  • Year by year, Non-cash Items stood at $2.6 million in 2022, then changed by 0.0% to $2.6 million in 2023, then tumbled by 90.0% to $258710.0 in 2024, then changed by 0.0% to $258710.0 in 2025.
  • Business Quant data shows Non-cash Items for ABVC at $258710.0 in Q4 2025, $258710.0 in Q3 2025, and $258710.0 in Q3 2024.